1:1 Bonus Share: LIC-backed multibagger penny stock at Rs 4.07; Board allots 15,36,24,538 fully paid-up rights equity shares 1:1 Bonus Share: LIC-backed multibagger penny stock at Rs 4.07; Board allots 15,36,24,538 fully paid-up rights equity shares The stock is up by 63 per cent from its 52-week low of Rs 2.50 per share & gave multibagger returns of over 600 per cent in just 3 years and a whopping 1,050 per cent in 5 years. Kiran Shroff / Tuesday, July 2, 2024 0 9894 Article rating: 4.4 The stock is up by 63 per cent from its 52-week low of Rs 2.50 per share & gave multibagger returns of over 600 per cent in just 3 years and a whopping 1,050 per cent in 5 years. Read more
Rakesh Jhunjhunwala’s portfolio multibagger pharma stock hit 20 per cent upper circuit & fresh 52-week high; Here’s why! Rakesh Jhunjhunwala’s portfolio multibagger pharma stock hit 20 per cent upper circuit & fresh 52-week high; Here’s why! The stock gave multibagger returns of 250 per cent in just 1 year whereas BSE Sensex Index is up by 23 per cent. Kiran Shroff / Tuesday, July 2, 2024 0 9944 Article rating: 4.3 The shares of the company saw a spurt in volume by more than 4.37 times on BSE. Read more
250 per cent multibagger returns and Heavy buying: This defence & aerospace stock bags new orders worth Rs 266 crore from Garden Reach Shipbuilders! 250 per cent multibagger returns and Heavy buying: This defence & aerospace stock bags new orders worth Rs 266 crore from Garden Reach Shipbuilders! Shares of the company have gained more than 100 per cent in the last six months. Praveenkumar Yadav / Tuesday, July 2, 2024 0 10966 Article rating: 4.1 Shares of the company have gained more than 100 per cent in the last six months. Read more
Vijay Kedia & Ashish Kacholia-backed gems & jewellery stock jumps over 10 per cent with spurt in volume by more than 4.5 times on BSE Vijay Kedia & Ashish Kacholia-backed gems & jewellery stock jumps over 10 per cent with spurt in volume by more than 4.5 times on BSE The stock is up by 26 per cent from its 52-week low of Rs 263.05 per share and gave multibagger returns of 120 per cent in 10 years. Kiran Shroff / Tuesday, July 2, 2024 0 15691 Article rating: 3.6 The company has a market cap of over Rs 5,500 crore and has been maintaining a healthy dividend payout of 71.1 per cent. Read more
Evaluating Emcure Pharmaceuticals Ltd IPO opportunity; Should you invest? Evaluating Emcure Pharmaceuticals Ltd IPO opportunity; Should you invest? In this analysis, we take a closer look at Emcure Pharmaceuticals Ltd and present you with the exclusive IPO details. Mandar Wagh / Tuesday, July 2, 2024 0 2877 Article rating: 4.7 In this analysis, we take a closer look at Emcure Pharmaceuticals Ltd and present you with the exclusive IPO details. Read more